About Growblox Sciences
Growblox Sciences, Inc. (Growblox) is engaged in developing technologies and processes to convert the cannabis plant into medicines, therapies and treatments for a range of ailments. The Company is involved in developing and utilizing technologies in plant biology, cultivation and extraction techniques, combined with biotechnology, to produce medical-grade cannabis, cannabis concentrates and cannabinoid therapies. Growblox intends to conduct its business operations, primarily through its subsidiaries in three operating units, which include Solutions, Sciences and Product divisions. Solutions division involves the development and use of its suite of controlled-climate indoor agricultural technology growing and cultivation Suites, the GrowBLOX. Science division is engaged in preclinical testing of its biopharmaceutical cannabinoid product prototypes. Products division intends to market the pharmaceutical, nutraceutical and cosmeceutical drugs and therapies.
Industry, Sector and Symbol:
- Sector: N/A
- Industry: N/A
- Sub-Industry: N/A
- Exchange: OTCMKTS
- Symbol: GBLX
- CUSIP:
Key Metrics:
- Previous Close: $0.28
- 50 Day Moving Average: $0.32
- 200 Day Moving Average: $0.28
- 52-Week Range: $0.11 - $0.45
- Trailing P/E Ratio: N/A
- P/E Growth: 0.00
- Market Cap: $18.06M
- Outstanding Shares: 64,495,000
Additional Links:
Consensus Ratings for Growblox Sciences (OTCMKTS:GBLX) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.| Ratings Breakdown: | No ratings tracked in the last 12 months. |
| Consensus Rating: | N/A (Score: NaN) |
| Consensus Price Target: | N/A |
Analysts' Ratings History for Growblox Sciences (OTCMKTS:GBLX)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for Growblox Sciences (OTCMKTS:GBLX)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Growblox Sciences (OTCMKTS:GBLX)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Growblox Sciences (OTCMKTS:GBLX)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Growblox Sciences (OTCMKTS:GBLX)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 10/8/2014 | Lazarus Management Co Llc | Major Shareholder | Buy | 77,700 | $0.69 | $53,613.00 |  |
| 10/2/2014 | Lazarus Management Co Llc | Major Shareholder | Buy | 39,605 | $0.85 | $33,664.25 | |
| 9/29/2014 | Lazarus Management Co Llc | Major Shareholder | Buy | 64,000 | $0.90 | $57,600.00 | |
| 9/17/2014 | Lazarus Management Co Llc | Major Shareholder | Buy | 47,640 | $0.76 | $36,206.40 | |
| 8/27/2014 | Israel Opportunities F Lazarus | Major Shareholder | Buy | 46,625 | $1.05 | $48,956.25 | |
| 8/1/2014 | Israel Opportunities F Lazarus | Major Shareholder | Buy | 39,800 | $1.24 | $49,352.00 | |
| 7/30/2014 | Israel Opportunities F Lazarus | Major Shareholder | Buy | 87,077 | $1.24 | $107,975.48 | |
| 7/2/2014 | Lazarus Investment Partners Ll | Major Shareholder | Buy | 269,632 | $1.19 | $320,862.08 | |
| 6/2/2014 | Lazarus Management Co Llc | Major Shareholder | Buy | 1,000,000 | $0.50 | $500,000.00 | |
(Data available from 1/1/2013 forward)
Latest Headlines for Growblox Sciences (OTCMKTS:GBLX)| Date | Headline |
|---|
 | GROWBLOX SCIENCES, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities (OTCMKTS:GBLX)
biz.yahoo.com - September 9 at 4:59 PM |
 | Medical cannabis industry steadily taking off in P.R. (OTCMKTS:GBLX)
newsismybusiness.com - August 15 at 11:56 AM |
| GROWBLOX SCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Princi (OTCMKTS:GBLX)
biz.yahoo.com - August 11 at 5:24 PM |
| CANADIAN PHARMACIES SHIPPING TO USA - (OTCMKTS:GBLX)
www.tuscolatoday.com - August 2 at 9:58 AM |
| Growblox Sciences, Inc. with Pacific Leaf Partners LLC, Announces Ownership of Flagship Teco Medical Cannabis Growing Facility (OTCMKTS:GBLX)
finance.yahoo.com - July 26 at 8:30 AM |
| Letter To Growblox Sciences, Inc. Shareholders From Its CEO (OTCMKTS:GBLX)
finance.yahoo.com - July 25 at 8:30 AM |
| Growblox Sciences Forms Growblox Life Sciences, LLC, A Research Organization Focused on Medical Cannabis Scientific Discoveries (OTCMKTS:GBLX)
finance.yahoo.com - July 19 at 9:30 AM |
| GROWBLOX SCIENCES, INC. Files SEC form 10-K, Annual Report (OTCMKTS:GBLX)
biz.yahoo.com - July 14 at 5:31 PM |
| Growblox Sciences, Inc. Announces The Opening Of Its First Medical Marijuana Dispensary: "Showgrow" In Las Vegas, Nevada (OTCMKTS:GBLX)
finance.yahoo.com - June 28 at 9:30 AM |
 | Growblox Sciences Inc (OTCMKTS:GBLX) Jumps Up On News (OTCMKTS:GBLX)
www.hotstocked.com - June 8 at 11:17 PM |
| GROWBLOX SCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement (OTCMKTS:GBLX)
biz.yahoo.com - June 7 at 5:17 PM |
| GrowBLOX Sciences, Inc. Announces Exclusive Rights To Kyle Kushman's Cannabis Brands, Strains And Genetics In The State Of Nevada (OTCMKTS:GBLX)
finance.yahoo.com - June 7 at 9:48 AM |
| Growblox Sciences Inc (OTCMKTS:GBLX) Surges (OTCMKTS:GBLX)
www.hotstocked.com - May 31 at 8:39 AM |
Growblox Sciences (OTCMKTS:GBLX) Chart for Wednesday, September, 28, 2016
